Indicative Announcement on Stock Trading Risk
Filed with SSE · · 3 pages · Chinese
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
- Announcement on Changing Signatory Certified Public Accountant
- Corrective Action Report on Measures Taken by the Tianjin Office of China Securities Regulatory Commission to Order the Company to Make Corrections and Issue Warning Letters to Relevant Personnel
- Announcement on Continuation of Procurement for Products of the Company and Its Subsidiaries that Are Scheduled to Be Selected for National Procurement Continuation After the Expiry of Agreement
- Announcement on Receiving Decision on Administrative Supervision Measures from Tianjin Securities Regulatory Bureau
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs by the Subsidiary
- Announcement on Serious Abnormal Fluctuations in Stock Trading and Risk Warning
- Announcement on the 2025 Evaluation Report on ""Corporate Value and Return Enhancement"" and 2026 Action Plan
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals